VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
VBI to receive up to $33 million in consideration, subject to achievement of certain activities, for: VBI’s manufacturing capabilities and certain related assets at Rehovot manufacturing facility Intellectual property for VBI-2601, VBI’s hepatiti